Invokana: MDL 2750

Introduction

Invokana: MDL 2750: In Re Invokana (Canagliflozin) Products Liability Litigation- created in December 2016, presided by Hon. Brian R. Martinotti, U.S.D.J, in the U.S. District Court for the District of New Jersey; First bellwether -September 2018. Cases are also filed in state courts, primarily in California, Pennsylvania, and New Jersey. As per the most recent court records, more than 1,000 Invokana lawsuits are currently pending the federal MDL and are in the pretrial discovery phase.

Comments

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Valsartan “Wave 2” Bellwether Trial Schedule Set by Court

Categories: Valsartan

As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.

This move comes in anticipation of the possibility that parties may…

Invokana: MDL 2750